CDEK
← All organizations

Cardinal Health

Academic/HospitalWebsite ↗

Also known as: Cardinal Health | CARDINAL HEALTH 414 | Cardinal Health 414, LLC | CARDINAL HEALTH 418 | CARDINAL HLTH 414

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Aug 1, 2015

First marketed drug

Feb 17, 1981

Last known activity

Jun 12, 2025

Timeline

1970s

  1. Jan 1, 1971

    Cardinal Health— Founded

1980s

  1. May 27, 1982

    sodium iodide i-123— NDA Secondary Org

1990s

  1. May 21, 1998

    R.P. Scherer— Acquired

2000s

  1. Dec 4, 2002

    Syncor International— Acquired

2010s

  1. Nov 13, 2015

    fludeoxyglucose f-18— Marketing Organization

Drugs by trial phase (4 distinct, 6 trials)

Phase 2 (4 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (8)

Subsidiaries (2 direct, 3 total across the full acquisition tree)

Recent trials (9)

Details

Founded
Dublin, OH, US Jan 1, 1971
Last known activity
Jun 12, 2025